Successful Nobel Biocare Global Symposium held in New York

6. Juli 2010, 07:00 MEZ

From 24 to 27 June 2010, Nobel Biocare held a Global Symposium dedicated to the promotion of innovative and scientifically proven solutions in dentistry. This exclusive three-day event brought together 1,500 world-renowned dental professionals from 46 countries. The symposium featured clinical treatment concepts, clinical applications, emerging technologies and advanced treatment planning. There was also a post symposium on fully edentulous solutions. This Global Symposium was the first in a series of similar events to be held in Asia and Europe.

Building on its more than 45-year heritage of science-based innovations, Nobel Biocare is organizing a series of symposia for 2010 that will allow dental professionals from around the world to exchange their latest know-how and professional experiences. The Global Symposium in New York marks the beginning of this series. The program for the symposium was developed by an independent scientific committee chaired by Dr Jonathan Ferencz, Clinical Professor at New York University’s College of Dentistry. The symposium focused on key topics such as immediate function, the contribution of emerging technologies to prosthetic success, optimization of soft tissue health outcomes to enhance long-term predictability, possibilities for fully edentulous treatments, advanced treatment planning and maxillofacial concepts. The program was accompanied by a broad array of educational seminars, hands-on training sessions and a post-symposium event on fully edentulous solutions including zygomatic implants.

Dr Jonathan Ferencz, Chairman of the Scientific Committee, said: “With this program, we wanted to highlight the patient benefits of the latest treatment modalities. Thanks to the vast concentration of expert dental knowledge and insight and the high quality of the opinion leaders in attendance, I am confident that we delivered a unique symposium of great academic and practical value and relevance to the participants. The Scientific Committee is very pleased with the outcome of the symposium.”

Domenico Scala, CEO of Nobel Biocare: “We are very pleased with the high quality the symposium offered and the fact that it attracted both existing and new customers. The large attendance and great interest attest to the fact that the treatment modalities discussed by the best dental experts in the industry are of great relevance to dental professionals. We are very fortunate that we could call on such a prestigious group of opinion leaders to share their expertise in an atmosphere of partnership and cooperation.”

The next Global Symposium will take place in Tokyo, Japan, in August 2010. Further regional/local symposia will be held in London, Stockholm, Zurich, Berlin, Barcelona, Rimini and Moscow during the second half of the year.

Details on upcoming Nobel Biocare events can be found online at:
www.nobelbiocare.com/events 
 

Kontakt Media Relations

Name: Nicolas Weidmann (Senior Vice President Communications)
Tel.: +41 43 211 42 80; +41 79 372 29 81
E-Mail: nicolas.weidmann@nobelbiocare.com

Kontakt Investor Relations

Name: Süha Demokan (Head of Investor Relations )
Tel.: +41 43 211 42 30; +41 79 430 81 46
E-Mail: suha.demokan@nobelbiocare.com
Nobel Biocare (NOBN, SIX Swiss Exchange) ist ein weltweit führendes Unternehmen für innovative restaurative und ästhetische Dentallösungen. Als Anbieterin von Gesamtlösungen verfügt Nobel Biocare von der Wurzel bis zum Zahn über die umfassendste Lösungspalette – von der Einzelzahnversorgung bis hin zur Restauration vollständig zahnloser Kiefer. Das Lösungsportfolio beinhaltet Zahnimplantate (inklusive der wichtigsten Marken NobelActive™, Brånemark System® und NobelReplace®), individualisierte Prothetik und Geräte (NobelProcera™), schablonengestützte Chirurgieverfahren und Biomaterialien. Nobel Biocare beschäftigt über 2400 Mitarbeitende und wies für 2011 einen Umsatz von EUR 569,2 Mio. aus. Das Unternehmen hat seinen Hauptsitz in Zürich, Schweiz. Produziert wird an sieben Standorten in Kanada, Israel, Japan, Schweden und den USA. Nobel Biocare verfügt über 34 direkte Verkaufsorganisationen.

Kontakt Media Relations

N Weidmann

Nicolas Weidmann

Senior Vice President Communications

Nobel Biocare Management AG
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 80

+41 79 372 29 81

+41 43 211 42 42

Ihr Feedback ist uns wichtig!

Summarize your comments
Email